BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2114763)

  • 1. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique.
    Hendrix LE; Kneeland JB; Haughton VM; Daniels DL; Szumowski J; Williams AL; Mark LP; Czervionke LF
    AJNR Am J Neuroradiol; 1990; 11(4):749-54. PubMed ID: 2114763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique.
    Hendrix LE; Kneeland JB; Haughton VM; Daniels DL; Szumowski J; Williams AL; Mark LP; Czervionke LF
    AJR Am J Roentgenol; 1990 Oct; 155(4):849-54. PubMed ID: 2119121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging.
    Guy J; Mao J; Bidgood WD; Mancuso A; Quisling RG
    Ophthalmology; 1992 May; 99(5):713-9. PubMed ID: 1594216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
    De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
    Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadopentetate-dimeglumine-enhanced MR imaging of gliomatosis cerebri: appearance mimicking leptomeningeal tumor dissemination.
    Rippe DJ; Boyko OB; Fuller GN; Friedman HS; Oakes WJ; Schold SC
    AJNR Am J Neuroradiol; 1990; 11(4):800-1. PubMed ID: 2114771
    [No Abstract]   [Full Text] [Related]  

  • 6. MR fat suppression combined with Gd-DTPA enhancement in optic neuritis and perineuritis.
    Tien RD; Hesselink JR; Szumowski J
    J Comput Assist Tomogr; 1991; 15(2):223-7. PubMed ID: 2002098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra- and paraorbital lesions: value of fat-suppression MR imaging with paramagnetic contrast enhancement.
    Tien RD; Chu PK; Hesselink JR; Szumowski J
    AJNR Am J Neuroradiol; 1991; 12(2):245-53. PubMed ID: 1902021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging of Sturge-Weber syndrome: role of gadopentetate dimeglumine and gradient-echo techniques.
    Elster AD; Chen MY
    AJNR Am J Neuroradiol; 1990; 11(4):685-9. PubMed ID: 2114749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.
    Mirowitz SA; Shady KL
    AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of gadopentetate dimeglumine for 1.5-T MR imaging of musculoskeletal masses: comparison with unenhanced T1- and T2-weighted imaging.
    Rosenthal RE; Wozney P
    J Magn Reson Imaging; 1991; 1(5):547-51. PubMed ID: 1790379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging.
    Okizuka H; Sugimura K; Yoshizako T; Kaji Y; Wada A
    J Magn Reson Imaging; 1996; 6(3):465-71. PubMed ID: 8724412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.
    Wessbecher FW; Maravilla KR; Dalley RW
    AJNR Am J Neuroradiol; 1991; 12(4):675-9. PubMed ID: 1882743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiologic-pathologic correlation: meningioma of the optic nerve sheath.
    Ortiz O; Schochet SS; Kotzan JM; Kostick D
    AJNR Am J Neuroradiol; 1996 May; 17(5):901-6. PubMed ID: 8733965
    [No Abstract]   [Full Text] [Related]  

  • 15. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging.
    Miki Y; Matsuo M; Nishizawa S; Kuroda Y; Keyaki A; Makita Y; Kawamura J
    Radiology; 1990 Oct; 177(1):35-8. PubMed ID: 2399335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign lumbar arachnoiditis: MR imaging with gadopentetate dimeglumine.
    Johnson CE; Sze G
    AJNR Am J Neuroradiol; 1990; 11(4):763-70. PubMed ID: 2114765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic nerve sheath meningioma. Definition of intraorbital, intracanalicular, and intracranial components with magnetic resonance imaging.
    Lindblom B; Truwit CL; Hoyt WF
    Ophthalmology; 1992 Apr; 99(4):560-6. PubMed ID: 1584575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-enhanced MR imaging in the management of a midline cerebral dysgerminoma.
    Hawes DR; Yuh WT; Wen BC
    Comput Med Imaging Graph; 1989; 13(6):463-8. PubMed ID: 2598155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat-suppression MR imaging in neuroradiology: techniques and clinical application.
    Tien RD
    AJR Am J Roentgenol; 1992 Feb; 158(2):369-79. PubMed ID: 1729800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR angiography of meningioma.
    Kadota T; Kuriyama K; Inoue E; Fujita M; Nakagawa H; Kuroda C
    Magn Reson Imaging; 1993; 11(4):473-83. PubMed ID: 8316060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.